沃里科纳能成功治疗青中的性菌病
Laura A Brannelly1, Preeti Sharma1,2, Sofia Ballesteros1
1Melbourne Veterinary School, Faculty of Science, The University of Melbourne, Werribee, Victoria 3030, Australia.
Diseases of aquatic organisms
|July 11, 2024
概括
沃里科纳能有效地治疗被囚禁两动物的菌菌,清除病原体并阻止死亡率. 与现有的两动物保护方法相比,这种抗真菌药物提供了更安全,更容易获得的治疗选择.
科学领域:
- 两动物疾病研究研究
- 兽医真菌学 兽医真菌学
- 保存医学是一种保存医学.
背景情况:
- 甲状腺瘤是全球两动物数量下降的主要驱动因素.
- 目前的治疗方法缺乏跨物种和生命阶段的广泛适用性.
- 对于受影响的两动物种群,迫切需要安全有效的治疗选择.
研究的目的:
- 评估沃里科纳作为一种在被囚禁两动物物种中治疗菌菌的治疗方法.
- 为了比较voriconazole治疗与现有方法的有效性和实用性.
- 评估voriconazole在两动物保护中更广泛应用的潜力.
主要方法:
- 两种治疗方案的voriconazole被给予两动物感染了菌菌.
- 通过病原体清除率和死亡率来评估治疗的有效性.
- 处理要求和设备需求与其他处理方式进行了比较.
主要成果:
- 沃里康纳治疗实现了百分之百的清除菌病原体.
- 在接受治疗的两动物中,沃里可纳给药后的死亡率停止了.
- 与伊特拉科纳或热处理相比,沃里科纳治疗需要更少的处理和没有专门的设备.
结论:
- 沃里科纳显示出作为至少一种两动物物种中胆菌的安全有效治疗方法的巨大潜力.
- 这种抗真菌剂在易于使用和适用性方面比目前的治疗方法具有优势.
- 建议进行进一步的临床试验,以确定和各种两动物物种的最佳剂量,治疗持续时间以及疗效/安全性.
关键词:
两动物两动物畜牧业 动物养殖 动物养殖巴特拉科希特 (Batrachochytrium dendrobatidis) 是一种类型的植物.封闭式管理是封闭式管理.这种疾病叫做cytridiomycosis.疾病的爆发是疾病的爆发.治疗方法 治疗方法沃里康纳 (Voriconazole) 是一种可以更多相关视频
12:29Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
10.3K
07:37Using Terminal Transferase-mediated dUTP Nick End-labelling TUNEL and Caspase 3/7 Assays to Measure Epidermal Cell Death in Frogs with Chytridiomycosis
Published on: May 16, 2018
10.6K
相关概念视频
Fungal Group Zygomycota
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Trichomoniasis
Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
